Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Globus Medical Analyst Ratings and Price Targets | NYSE:GMED | Benzinga
Globus Medical Inc has a consensus price target of $88.43 based on the ratings of 18 analysts. The high is $115 issued by Roth MKM on December 17, 2024. The low is $68 issued by Truist Securities on May 12, 2025. The 3 most-recent analyst ratings were released by Truist Securities, Piper Sandler, and Truist Securities on May 12, 2025, May 9, 2025, and April 11, 2025, respectively. With an average price target of $76 between Truist Securities, Piper Sandler, and Truist Securities, there's an implied 24.24% upside for Globus Medical Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Piper Sandler
Barclays
Stifel
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Globus Medical
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/27/2025 | Buy Now | — | JMP Securities | David Turkaly52% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 05/27/2025 | Buy Now | — | BTIG | Ryan Zimmerman70% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/12/2025 | Buy Now | 11.17% | Truist Securities | Richard Newitter74% | $80 → $68 | Maintains | Hold | Get Alert |
| 05/09/2025 | Buy Now | 30.78% | Piper Sandler | Matt O'Brien53% | $100 → $80 | Maintains | Overweight | Get Alert |
| 04/11/2025 | Buy Now | 30.78% | Truist Securities | Richard Newitter74% | $82 → $80 | Maintains | Hold | Get Alert |
| 03/18/2025 | Buy Now | 34.05% | Truist Securities | Richard Newitter74% | $90 → $82 | Maintains | Hold | Get Alert |
| 03/18/2025 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | Hold → Hold | Get Alert |
| 02/24/2025 | Buy Now | — | Citizens Capital Markets | David Turkaly52% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 02/24/2025 | Buy Now | 68.38% | Barclays | Matt Miksic66% | $100 → $103 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | 53.67% | Stifel | Mathew Blackman63% | $92 → $94 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 52.04% | Wells Fargo | Vik Chopra42% | $95 → $93 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | Hold → Hold | Get Alert |
| 02/06/2025 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | Hold → Hold | Get Alert |
| 01/10/2025 | Buy Now | 65.11% | Canaccord Genuity | William Plovanic60% | $92 → $101 | Maintains | Buy | Get Alert |
| 01/09/2025 | Buy Now | 58.57% | B of A Securities | Craig Bijou77% | $80 → $97 | Upgrade | Underperform → Neutral | Get Alert |
| 01/09/2025 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | Hold → Hold | Get Alert |
| 12/18/2024 | Buy Now | 47.13% | Truist Securities | Richard Newitter74% | $85 → $90 | Maintains | Hold | Get Alert |
| 12/17/2024 | Buy Now | 88% | Roth MKM | Jason Wittes53% | $100 → $115 | Maintains | Buy | Get Alert |
| 12/12/2024 | Buy Now | 48.77% | BTIG | Ryan Zimmerman70% | $87 → $91 | Maintains | Buy | Get Alert |
| 12/11/2024 | Buy Now | 55.3% | Wells Fargo | Vik Chopra42% | $88 → $95 | Maintains | Overweight | Get Alert |
| 12/09/2024 | Buy Now | 50.4% | Canaccord Genuity | William Plovanic60% | $85 → $92 | Maintains | Buy | Get Alert |
| 12/02/2024 | Buy Now | 63.48% | Morgan Stanley | Drew Ranieri46% | $83 → $100 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/11/2024 | Buy Now | 35.69% | Morgan Stanley | Drew Ranieri46% | $74 → $83 | Maintains | Equal-Weight | Get Alert |
| 11/07/2024 | Buy Now | 63.48% | Barclays | Matt Miksic66% | $93 → $100 | Maintains | Overweight | Get Alert |
| 11/07/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 11/06/2024 | Buy Now | 50.4% | Stifel | Mathew Blackman63% | $80 → $92 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 38.96% | Canaccord Genuity | William Plovanic60% | $79 → $85 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 63.48% | Roth MKM | Jason Wittes53% | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2024 | Buy Now | 50.4% | RBC Capital | Shagun Singh57% | $80 → $92 | Maintains | Outperform | Get Alert |
| 11/06/2024 | Buy Now | 43.86% | Wells Fargo | Vik Chopra42% | $78 → $88 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | 63.48% | Piper Sandler | Matt O'Brien53% | $80 → $100 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | 30.78% | B of A Securities | Craig Bijou77% | $55 → $80 | Maintains | Underperform | Get Alert |
| 11/06/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 10/14/2024 | Buy Now | 27.51% | BTIG | Ryan Zimmerman70% | $77 → $78 | Maintains | Buy | Get Alert |
| 10/08/2024 | Buy Now | 30.78% | RBC Capital | Shagun Singh57% | $78 → $80 | Maintains | Outperform | Get Alert |
| 08/28/2024 | Buy Now | 25.88% | BTIG | Ryan Zimmerman70% | $75 → $77 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | 52.04% | Barclays | Matt Miksic66% | $85 → $93 | Maintains | Overweight | Get Alert |
| 08/07/2024 | Buy Now | 27.51% | RBC Capital | Shagun Singh57% | $76 → $78 | Maintains | Outperform | Get Alert |
| 08/07/2024 | Buy Now | 29.15% | Truist Securities | Richard Newitter74% | $78 → $79 | Maintains | Hold | Get Alert |
| 08/07/2024 | Buy Now | 27.51% | Wells Fargo | Vik Chopra42% | $60 → $78 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/07/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 07/16/2024 | Buy Now | 27.51% | Truist Securities | Richard Newitter74% | $63 → $78 | Maintains | Hold | Get Alert |
| 07/15/2024 | Buy Now | 22.61% | BTIG | Ryan Zimmerman70% | $72 → $75 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | 16.07% | Morgan Stanley | Drew Ranieri46% | $67 → $71 | Maintains | Equal-Weight | Get Alert |
| 05/29/2024 | Buy Now | 17.7% | BTIG | Ryan Zimmerman70% | $63 → $72 | Maintains | Buy | Get Alert |
| 05/20/2024 | Buy Now | 30.78% | Piper Sandler | Matt O'Brien53% | $60 → $80 | Upgrade | Neutral → Overweight | Get Alert |
| 05/09/2024 | Buy Now | 38.96% | Barclays | Matt Miksic66% | $83 → $85 | Maintains | Overweight | Get Alert |
| 05/08/2024 | Buy Now | 2.99% | BTIG | Ryan Zimmerman70% | $60 → $63 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | -1.91% | Piper Sandler | Matt O'Brien53% | $55 → $60 | Maintains | Neutral | Get Alert |
| 05/08/2024 | Buy Now | 14.44% | Stifel | Mathew Blackman63% | $64 → $70 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | — | Needham | David Saxon56% | — | Reiterates | → Hold | Get Alert |
| 03/18/2024 | Buy Now | -1.91% | BTIG | Ryan Zimmerman70% | → $60 | Upgrade | Neutral → Buy | Get Alert |
| 02/21/2024 | Buy Now | 29.15% | Canaccord Genuity | Caitlin Cronin43% | → $79 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2024 | Buy Now | -1.91% | Truist Securities | Richard Newitter74% | $58 → $60 | Maintains | Hold | Get Alert |
| 01/11/2024 | Buy Now | 14.44% | RBC Capital | Shagun Singh57% | $70 → $70 | Reiterates | Outperform → Outperform | Get Alert |
| 12/22/2023 | Buy Now | -5.18% | Truist Securities | Richard Newitter74% | $53 → $58 | Maintains | Hold | Get Alert |
| 12/20/2023 | Buy Now | 16.07% | Canaccord Genuity | Kyle Rose68% | $67 → $71 | Maintains | Buy | Get Alert |
| 11/14/2023 | Buy Now | -13.36% | Morgan Stanley | Drew Ranieri46% | $60 → $53 | Maintains | Equal-Weight | Get Alert |
| 11/08/2023 | Buy Now | -13.36% | Truist Securities | Richard Newitter74% | $58 → $53 | Maintains | Hold | Get Alert |
| 10/20/2023 | Buy Now | 22.61% | Roth MKM | Jason Wittes53% | → $75 | Initiates | → Buy | Get Alert |
| 10/12/2023 | Buy Now | 40.59% | Barclays | Matt Miksic66% | $77 → $86 | Maintains | Overweight | Get Alert |
| 09/19/2023 | Buy Now | -0.28% | Stifel | Mathew Blackman63% | → $61 | Upgrade | Hold → Buy | Get Alert |
| 09/15/2023 | Buy Now | -5.18% | Wells Fargo | Vik Chopra42% | $63 → $58 | Maintains | Equal-Weight | Get Alert |
| 09/05/2023 | Buy Now | 6.26% | Truist Securities | Richard Newitter74% | → $65 | Reiterates | Hold → Hold | Get Alert |
| 08/07/2023 | Buy Now | 6.26% | Truist Securities | Richard Newitter74% | $68 → $65 | Maintains | Hold | Get Alert |
| 08/07/2023 | Buy Now | 25.88% | Barclays | Matt Miksic66% | $75 → $77 | Maintains | Overweight | Get Alert |
| 08/04/2023 | Buy Now | 2.99% | Wells Fargo | Vik Chopra42% | $61 → $63 | Maintains | Equal-Weight | Get Alert |
| 07/19/2023 | Buy Now | 11.17% | Truist Securities | Richard Newitter74% | $64 → $68 | Maintains | Hold | Get Alert |
| 05/31/2023 | Buy Now | -1.91% | Morgan Stanley | Drew Ranieri46% | $64 → $60 | Maintains | Equal-Weight | Get Alert |
| 05/24/2023 | Buy Now | — | JMP Securities | David Turkaly52% | — | Reiterates | → Market Perform | Get Alert |
| 05/05/2023 | Buy Now | 4.63% | Truist Securities | Richard Newitter74% | $66 → $64 | Maintains | Hold | Get Alert |
| 03/30/2023 | Buy Now | 9.53% | Canaccord Genuity | Kyle Rose68% | → $67 | Upgrade | Hold → Buy | Get Alert |
| 03/28/2023 | Buy Now | 9.53% | Canaccord Genuity | Kyle Rose68% | → $67 | Reiterates | → Hold | Get Alert |
| 02/22/2023 | Buy Now | 4.63% | Morgan Stanley | Drew Ranieri46% | $78 → $64 | Maintains | Equal-Weight | Get Alert |
| 02/22/2023 | Buy Now | 9.53% | Canaccord Genuity | Kyle Rose68% | $75 → $67 | Maintains | Hold | Get Alert |
| 02/22/2023 | Buy Now | -0.28% | Wells Fargo | Vik Chopra42% | $67 → $61 | Maintains | Equal-Weight | Get Alert |
| 02/13/2023 | Buy Now | 2.99% | B of A Securities | Craig Bijou77% | $83 → $63 | Downgrade | Buy → Underperform | Get Alert |
| 02/10/2023 | Buy Now | 9.53% | Wells Fargo | Vik Chopra42% | $82 → $67 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/10/2023 | Buy Now | 14.44% | Truist Securities | Richard Newitter74% | → $70 | Downgrade | Buy → Hold | Get Alert |
| 02/10/2023 | Buy Now | 14.44% | Loop Capital | Jason Wittes53% | $90 → $70 | Downgrade | Buy → Hold | Get Alert |
| 02/10/2023 | Buy Now | — | Needham | David Saxon56% | — | Downgrade | Buy → Hold | Get Alert |
| 02/10/2023 | Buy Now | — | BTIG | Ryan Zimmerman70% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/09/2023 | Buy Now | — | Piper Sandler | Matt O'Brien53% | — | Downgrade | Overweight → Neutral | Get Alert |
| 01/06/2023 | Buy Now | 27.51% | Morgan Stanley | Drew Ranieri46% | $68 → $78 | Maintains | Equal-Weight | Get Alert |
| 12/20/2022 | Buy Now | 38.96% | Truist Securities | Richard Newitter74% | $74 → $85 | Maintains | Buy | Get Alert |
| 12/12/2022 | Buy Now | 34.05% | Wells Fargo | Vik Chopra42% | $74 → $82 | Maintains | Overweight | Get Alert |
| 11/09/2022 | Buy Now | 11.17% | Morgan Stanley | Drew Ranieri46% | $66 → $68 | Maintains | Equal-Weight | Get Alert |
| 10/18/2022 | Buy Now | 12.8% | Barclays | Matt Miksic66% | → $69 | Initiates | → Overweight | Get Alert |
| 10/12/2022 | Buy Now | 22.61% | Jefferies | Matthew Taylor69% | → $75 | Initiates | → Buy | Get Alert |
| 10/11/2022 | Buy Now | 7.9% | Morgan Stanley | Drew Ranieri46% | $62 → $66 | Maintains | Equal-Weight | Get Alert |
| 08/05/2022 | Buy Now | 22.61% | Piper Sandler | Matt O'Brien53% | $80 → $75 | Maintains | Overweight | Get Alert |
| 07/20/2022 | Buy Now | 16.07% | Truist Securities | Richard Newitter74% | $76 → $71 | Maintains | Buy | Get Alert |
| 07/15/2022 | Buy Now | 1.36% | Morgan Stanley | Drew Ranieri46% | $68 → $62 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Globus Medical (GMED) stock?
The latest price target for Globus Medical (NYSE:GMED) was reported by JMP Securities on May 27, 2025. The analyst firm set a price target for $0.00 expecting GMED to fall to within 12 months (a possible -100.00% downside). 44 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Globus Medical (GMED)?
The latest analyst rating for Globus Medical (NYSE:GMED) was provided by JMP Securities, and Globus Medical reiterated their market perform rating.
When was the last upgrade for Globus Medical (GMED)?
The last upgrade for Globus Medical Inc happened on January 9, 2025 when B of A Securities raised their price target to $97. B of A Securities previously had an underperform for Globus Medical Inc.
When was the last downgrade for Globus Medical (GMED)?
The last downgrade for Globus Medical Inc happened on May 27, 2025 when BTIG changed their price target from N/A to N/A for Globus Medical Inc.
When is the next analyst rating going to be posted or updated for Globus Medical (GMED)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Globus Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Globus Medical was filed on May 27, 2025 so you should expect the next rating to be made available sometime around May 27, 2026.
Is the Analyst Rating Globus Medical (GMED) correct?
While ratings are subjective and will change, the latest Globus Medical (GMED) rating was a reiterated with a price target of $0.00 to $0.00. The current price Globus Medical (GMED) is trading at is $61.16, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
